Clinical Trials Directory

Trials / Conditions / Recurrent Gastric Carcinoma

Recurrent Gastric Carcinoma

8 registered clinical trials studyying Recurrent Gastric Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
NCT04550494
National Cancer Institute (NCI)Phase 2
TerminatedHeated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatr
NCT04213794
Mayo ClinicEARLY_Phase 1
CompletedOlaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal
NCT03008278
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedEpacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction o
NCT03196232
George Albert FisherPhase 2
Active Not RecruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph
NCT02465060
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
Roswell Park Cancer InstitutePhase 1
CompletedAkt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
NCT01260701
National Cancer Institute (NCI)Phase 2
CompletedPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gast
NCT01178944
Roswell Park Cancer InstitutePhase 2